✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Lasa Supergenerics Ltd.

LASA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹66 Cr.
P/E
0.00

Lasa Supergenerics Ltd.

  • Lasa Supergenerics
  • Mangalam Drugs&Org.
  • Bal Pharma

FAQs on Lasa Supergenerics Ltd. Shareprice

Lasa Supergenerics has given lower returns compared to its competitors.
Lasa Supergenerics has grown at ~-8.58% over the last 7yrs while peers have grown at a median rate of 7.06%

Lasa Supergenerics is not expensive.
Latest PE of Lasa Supergenerics is 0.0, while 3 year average PE is 2.1.
Also latest EV/EBITDA of Lasa Supergenerics is 14.99 while 3yr average is 20.77.

View FAQ's On Business

Growth Table

  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Balance Sheet

  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Cash Flow

  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Quarterly Results

  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Bal Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Lasa Supergenerics Ltd. Financials

Lasa Supergenerics balance sheet is weak and might have solvency issues

The net debt of Lasa Supergenerics is decreasing.
Latest net debt of Lasa Supergenerics is ₹1.34 Crs as of Mar-25.
This is less than Mar-24 when it was ₹19.18 Crs.

The profit is oscillating.
The profit of Lasa Supergenerics is -₹33.15 Crs for TTM, -₹21.73 Crs for Mar 2024 and -₹38.62 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lasa Supergenerics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech